Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 11
Submit an article Journal homepage
323
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Long-term response to maintenance treatment with rituximab in CD20+ multiple myeloma

Hitoshi OhnoDepartment of Hematology, Takeda General Hospital, Kyoto, JapanCorrespondence[email protected]
Pages 2144-2146 | Received 11 Jun 2010, Accepted 01 Aug 2010, Published online: 31 Aug 2010

References

  • Vidal L, Gafter-Gvili A, Leibovici L, et al Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst 2009;101:248–255.
  • Heerema-McKenney A, Waldron J, Hughes S, et al Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma. Am J Clin Pathol 2010;133:265–270.
  • Robillard N, Avet-Loiseau H, Garand R, et al CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood 2003;102:1070–1071.
  • Kapoor P, Greipp PT, Morice WG, Rajkumar SV, Witzig TE, Greipp PR. Anti-CD20 monoclonal antibody therapy in multiple myeloma. Br J Haematol 2008;141:135–148.
  • Baz R, Fanning S, Kunkel L, et al Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma. Leuk Lymphoma 2007;48:2338–2344.
  • Bergua JM, Cabrera C, Arteta EG, Prieto J. Rituximab in CD20 positive multiple myeloma. Leukemia 2008;22:1082–1083.
  • Korte W, Jost C, Cogliatti S, Hess U, Cerny T. Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy. Ann Oncol 1999;10:1249–1250.
  • Moreau P, Voillat L, Benboukher L, et al Rituximab in CD20 positive multiple myeloma. Leukemia 2007;21:835–836.
  • Zojer N, Kirchbacher K, Vesely M, Hubl W, Ludwig H. Rituximab treatment provides no clinical benefit in patients with pretreated advanced multiple myeloma. Leuk Lymphoma 2006;47:1103–1109.
  • Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842–854.
  • Greipp PR, San Miguel J, Durie BG, et al International staging system for multiple myeloma. J Clin Oncol 2005;23:3412–3420.
  • Matsui W, Huff CA, Wang Q, et al Characterization of clonogenic multiple myeloma cells. Blood 2004;103:2332–2336.
  • Jones RJ, Matsui WH, Smith BD. Cancer stem cells: are we missing the target? J Natl Cancer Inst 2004;96:583–585.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.